Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,724
datasets available to search
ShareScore release 0.9.0
Dataset results
1,724 results for “ESCALATOR”
Suppression force-fields and diffuse competition: Competition de-escalation is an evolutionarily stable strategy
Open the record for dataset details and reuse information.
Escalated begging does not compromise nestling health
Open the record for dataset details and reuse information.
Riding an escalator: upward range shift and patterns of genetic response to climate change in Acer caudatifolium
<p><strong>Aim </strong></p> <p>Rapid global warming is threatening global biodiversity, and it will likely lead to varying degrees of local adaptation, particularly among plant species. Besides, rising temperatures frequently result in upslope distribution shifts towards climatic optima (i.e., the escalator effect) within a limited dispersal space, such as in insular environments. Here, we integrated ecological and genetic approaches to investigate how climate change will impact the genetic compositions and spatial distributions of Taiwan endemic maple <em>Acer caudatifolium</em>.</p> <p><strong>Location </strong></p> <p>Taiwan</p> <p><strong>Methods </strong></p> <p>We estimate the distribution range shifts of <em>A. caudatifolium</em> under climate change through species distribution modeling (SDM). We also use 368 genotyped samples to infer dispersal and genetic hotspots and quantify the contributions of geography/environments to genetic variations. We further assess the potential risk to <em>A. caudatifolium</em> under different climate warming scenarios.</p> <p><strong>Results </strong></p> <p>We detected three genetic diversity hotspots near mountainous glacial refugia and two dispersal hotspots in northern Taiwan and the central-to-southern Central Mountain Range. Overall range reductions and an altitudinal upslope-shift were observed in SDM. Using both linear and nonlinear regression approaches, we found that genetic variation was significantly associated with geographic distance and elevation-related climatic variables. The potential risk analysis revealed that the northernmost summit-dwelling populations were the most vulnerable. Furthermore, the major risk factor differed among populations: for central populations, temperature and precipitation jointly determined the potential risk, whereas precipitation was the only risk factor for northern and southern populations.</p> <p><strong>Main conclusions</strong></p> <p>This case study demonstrates how various climate factors, mountain height, and the availability of corridors jointly determine the demographic fates and sustainability of island maples in the face of climate change. This study also provided estimates of the implications of global warming, which can be conducive to developing appropriate conservation strategies.</p>
Escales Vaixells 2019 - Port de Tarragona
<p>Dataset de les escales de vaixells al Port de Tarragona durant el 2019 obtingut a través del scraper del repositori https://github.com/arnaugiribet/scrapings</p>
Evaluating Risk Progression in Mental Health Chatbots with Escalating Prompts Dataset
<p>Excel dataset for "Evaluating Risk Progression in Mental Health Chatbots with Escalating Prompts" manuscript. </p>
One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study
ClinicalTrials.gov study NCT00580788. IPD Sharing: NO. Countries: 1. Publications: 27.
Dose-Escalation Trial of Carfilzomib With and Without Romidepsin in Cutaneous T-Cell Lymphoma
ClinicalTrials.gov study NCT01738594. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase I Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of BVD-523 in Patients With Advanced Malignancies
ClinicalTrials.gov study NCT01781429. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Intra-patient Dose Escalation Study to Investigate Safety and Feasibility of Vactosertib in Treating Anemic MPN Patients
ClinicalTrials.gov study NCT04103645. IPD Sharing: NO. Countries: 1. Publications: 34.
This Is The First Study Using Escalating Doses Of PF-03758309, An Oral Compound, In Patients With Advanced Solid Tumors
ClinicalTrials.gov study NCT00932126. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Dose Escalation Study of KB001 in Cystic Fibrosis Patients Infected With Pseudomonas Aeruginosa
ClinicalTrials.gov study NCT00638365. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase I, Multicenter Dose Escalation Study in Patients With Hairy Cell Leukemia
ClinicalTrials.gov study NCT00586924. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Dose Escalation Trial of AZD1775 and Gemcitabine (+Radiation) for Unresectable Adenocarcinoma of the Pancreas
ClinicalTrials.gov study NCT02037230. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase 1/2, Open-Label, Dose-Escalation, Safety Study of INCAGN01949 in Subjects With Advanced or Metastatic Solid Tumors
ClinicalTrials.gov study NCT02923349. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Study Escalating Doses of PM01183 in Combination With Fixed Doxorubicin in Patients With Specific Advanced Unresectable Solid Tumors
ClinicalTrials.gov study NCT01970540. IPD Sharing: Not stated. Countries: 2. Publications: 1.
An Open-label, Dose-escalation Safety and Tolerability Trial Assessing Anti-KIR (1-7F9) in Subjects With Multiple Myeloma
ClinicalTrials.gov study NCT00552396. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid Tumors
ClinicalTrials.gov study NCT02573259. IPD Sharing: NO. Countries: 7. Publications: 3.
A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD) and Clinical Activity of GSK525762 in Subjects With Relapsed, Refractory Hematologic Malignancies
ClinicalTrials.gov study NCT01943851. IPD Sharing: YES. Countries: 5. Publications: 1.
Dose Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2849330 in Subjects With Advanced Her3-Positive Solid Tumors
ClinicalTrials.gov study NCT01966445. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)
ClinicalTrials.gov study NCT01976741. IPD Sharing: Not stated. Countries: 7. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.